The Blood Stream Infection Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of blood stream infection testing has experienced a swift expansion in recent years. The market was worth $7.59 billion in 2024 and is projected to reach $8.49 billion in 2025. The compound annual growth rate (CAGR) during this period is expected to be 11.9%.
The Blood Stream Infection Testing Global Market Report 2025 predicts that by 2029, the blood dialyzer market will increase to $6.75 billion, with a compound annual growth rate (CAGR) of 5.8%.
Download Your Free Sample of the 2025 Blood Stream Infection Testing Market Report and Uncover Key Trends Now!The key drivers in the blood stream infection testing market are:
• Increasing demand for rapid diagnostic tests
• Growing adoption of molecular diagnostics
• Rising focus on personalized medicine
• Government initiatives for infection control
The blood stream infection testing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents and Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software and Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services
The key trends in the blood stream infection testing market are:
• The use of AI in diagnostic tools is emerging as a significant trend.
• Integration of diagnostic services with telemedicine is gaining prominence.
• There is an increasing demand for home-based testing kits.
• Development of multiplex diagnostic platforms and partnerships between diagnostic companies and hospitals are on the rise.
Major players in the blood stream infection testing market are:
• Medtronic plc
• Fresenius Medical Care AG & Co KGaA
• Asahi Kasei Medical Co. Ltd.
• Toray Industries Inc.
• Baxter International Inc.
• DaVita Healthcare Partners Inc.
• Nipro Corporation
• Shandong Weigao Group Medical Polymer Company Limited
• Nikkiso Co. Ltd.
• Lepu Medical Technology Co. Ltd.
• Nxstage Medical Inc.
• Jiangxi Sanxin Medtec Co. Ltd.
• Bain Medical Equipment Co. Ltd.
• Polymed Medical Devices
• SB-Kawasumi Laboratories Inc.
• Bioteque Corporation
• Farmasol
• Medica S.p.A.
• Browdove Healthcare Ltd.
• Allmed Medical Care Holding Limited
• JMS Co. Ltd.
• Jihua Medical Apparatus and Instruments Co. Ltd.
North America was the largest region in the blood stream infection testing market in 2024